Botaneco Corp  

(Public, CVE:AVI)   Watch this stock  
Find more results for AVI
0.0000
- Close
CVE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 0.09 - 0.34
Open     -
Vol / Avg. 0.00/49,210.00
Mkt cap 2.58M
P/E     -
Div/yield     -
EPS -0.14
Shares 25.77M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin -77.94% -206.86%
Operating margin -59.66% -206.15%
EBITD margin - -143.00%
Return on average assets -60.65% -70.35%
Return on average equity -358.05% -178.72%
Employees 15 -
Carbon Disclosure Rating - -

Address

134, 2985 23rd Ave NE
CALGARY, AB T1Y 7L3
Canada
+1-403-6686685 (Phone)
+1-403-6684789 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

Botaneco Corp. (formerly Advitech Inc.) is a health sciences and technology company. The Company is engaged in developing and marketing natural ingredients and oral and topical formulations targeting skin health and well being. The Company operates in three segments: Botaneco Corp, Botaneco Specialty and Natunola. The Company's Botaneco Corp segment sells Dermylex a natural health supplement derived from a certain whey protein that has been usedin treating mild to moderate symptoms of psoriasis. The Company's Botaneco Specialty segment is engaged in selling Hydresia an oleosome ingredient for various cosmetic, personal care and prescription topical dermatology products. The Company's Natunola segment sells both Gels and Extracts for personal care products and de-hulled flax seed into the natural food sector. In March 2013, the Company disposed its wholly-owned subsidiary, Botaneco Specialty Ingredients Inc.

Officers and directors

David Edwards Chairman of the Board
Aki Georgacacos Interim President, Director
Nam Fong Han Chief Executive Officer, Chief Operating Officer, Director
Lianne Tibben Chief Financial Officer
David D. Guebert CPA Lead Independent Director
Louis P. Lacasse Director